Back
Karyopharm Therapeutics Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
24
KPTI
Karyopharm Therapeutics
Last Price:
$4.33
Seasonality Move:
-7.27%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing slight buying pressure.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.06 | Buy |
| 20-day SMA: | 4.68 | Sell |
| 50-day SMA: | 6.9 | Sell |
| 200-day SMA: | 10.78 | Sell |
| 8-day EMA: | 4.17 | Buy |
| 20-day EMA: | 4.78 | Sell |
| 50-day EMA: | 6.47 | Sell |
| 200-day EMA: | 10.82 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 37.33 | Sell |
| Chaikin Money Flow: | 21650 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.86 - 6.4) | Sell |
| Bollinger Bands (100): | (6.27 - 11.53) | Sell |
Karyopharm Therapeutics Technical Analysis
| Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 4.21 while KPTI 8-day simple moving average is 4.06, which is a Buy signal.
-
The stock price of KPTI is 4.21 while Karyopharm Therapeutics 20-day SMA is 4.68, which makes it a Sell.
-
Karyopharm Therapeutics 50-day simple moving average is 6.90 while KPTI share price is 4.21, making it a Sell technically.
-
KPTI stock price is 4.21 and Karyopharm Therapeutics 200-day simple moving average is 10.78, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
24
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a SellThe current Karyopharm Therapeutics [KPTI] share price is $4.21. The Score for KPTI is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
35.4M
Price in USD:
4.21
Share Volume:
173.2K
Karyopharm Therapeutics 52-Week Range
52-Week High:
21.30
52-Week Low:
3.51
Sell
24
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?The Karyopharm Therapeutics stock price is 4.21 USD today.
-
Will KPTI stock go up or go down?Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Karyopharm Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
-
Karyopharm Therapeutics share price is 4.21 while KPTI 8-day exponential moving average is 4.17, which is a Buy signal.
-
The stock price of KPTI is 4.21 while Karyopharm Therapeutics 20-day EMA is 4.78, which makes it a Sell.
-
Karyopharm Therapeutics 50-day exponential moving average is 6.47 while KPTI share price is 4.21, making it a Sell technically.
-
KPTI stock price is 4.21 and Karyopharm Therapeutics 200-day simple moving average is 10.82, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.00 per share, a decrease next quarter of $2.05 per share, a decrease this year of $1.95 per share, and an increase next year of $2.97 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
-
KPTI Moving Average Covergence Divergence (MACD) indicator is -0.84, suggesting Karyopharm Therapeutics is a Sell
-
Karyopharm Therapeutics Relative Strength Index (RSI) is 37.33, which suggest Karyopharm Therapeutics is oversold
-
The Bollinger Bands (25) for Karyopharm Therapeutics is (3.86 - 6.4), which suggest Karyopharm Therapeutics is a Sell
-
The Bollinger Bands (100) for Karyopharm Therapeutics is (6.27 - 11.53), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.